These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31456471)

  • 41. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
    Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
    Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A holistic approach to targeting disease with polymeric nanoparticles.
    Cheng CJ; Tietjen GT; Saucier-Sawyer JK; Saltzman WM
    Nat Rev Drug Discov; 2015 Apr; 14(4):239-47. PubMed ID: 25598505
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanoparticle-mediated drug delivery and gene therapy.
    Jin S; Ye K
    Biotechnol Prog; 2007; 23(1):32-41. PubMed ID: 17269667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanoparticle-mediated drug delivery system for cardiovascular disease.
    Matoba T; Egashira K
    Int Heart J; 2014; 55(4):281-6. PubMed ID: 24942639
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine.
    Lepeltier EA; Nuhn L; Lehr CM; Zentel R
    Nanomedicine (Lond); 2015; 10(20):3147-66. PubMed ID: 26447353
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymeric nanoparticles: the future of nanomedicine.
    Banik BL; Fattahi P; Brown JL
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(2):271-99. PubMed ID: 26314803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanomedicine and veterinary science: the reality and the practicality.
    Underwood C; van Eps AW
    Vet J; 2012 Jul; 193(1):12-23. PubMed ID: 22365842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nanomedicine for treatment of diabetes in an aging population: state-of-the-art and future developments.
    Krol S; Ellis-Behnke R; Marchetti P
    Nanomedicine; 2012 Sep; 8 Suppl 1():S69-76. PubMed ID: 22640905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases.
    Sharma PA; Maheshwari R; Tekade M; Tekade RK
    Curr Pharm Des; 2015; 21(30):4465-78. PubMed ID: 26354926
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Understanding cardiovascular drug interactions.
    Porterfield LM; Porterfield JG
    Focus Crit Care; 1990 Oct; 17(5):412-6. PubMed ID: 2226975
    [No Abstract]   [Full Text] [Related]  

  • 54. Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
    Psarros C; Lee R; Margaritis M; Antoniades C
    Nanomedicine; 2012 Sep; 8 Suppl 1():S59-68. PubMed ID: 22640906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chitosan nanoparticles for oral drug and gene delivery.
    Bowman K; Leong KW
    Int J Nanomedicine; 2006; 1(2):117-28. PubMed ID: 17722528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nanocarriers & drug delivery: rational design and applications.
    Garcia-Fuentes M; Gonzalez-Díaz H; Csaba N
    Curr Top Med Chem; 2014; 14(9):1095-6. PubMed ID: 24678712
    [No Abstract]   [Full Text] [Related]  

  • 57. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
    Tam VH; Sosa C; Liu R; Yao N; Priestley RD
    Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanomedicine for Intranasal Delivery to Improve Brain Uptake.
    Patel AA; Patel RJ; Patel SR
    Curr Drug Deliv; 2018; 15(4):461-469. PubMed ID: 29034836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanobiotechnology-based strategies for crossing the blood-brain barrier.
    Jain KK
    Nanomedicine (Lond); 2012 Aug; 7(8):1225-33. PubMed ID: 22931448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.